- Home
- LNTH vs CVCO Comparison
LNTH vs CVCO Comparison
Compare LNTH & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | CVCO |
|---|---|---|
| Founded | 1956 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.6B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | CVCO |
|---|---|---|
| Price | $63.31 | $578.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $74.17 | ★ $550.00 |
| AVG Volume (30 Days) | ★ 1.1M | 127.9K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.54 |
| EPS | 2.39 | ★ 24.29 |
| Revenue | $1,525,933,000.00 | ★ $2,143,782,000.00 |
| Revenue This Year | $0.01 | $15.26 |
| Revenue Next Year | $1.24 | $8.18 |
| P/E Ratio | $26.45 | ★ $23.82 |
| Revenue Growth | 1.95 | ★ 15.76 |
| 52 Week Low | $47.25 | $393.53 |
| 52 Week High | $111.29 | $613.77 |
Technical Indicators
Market Signals| Indicator | LNTH | CVCO |
|---|---|---|
| Relative Strength Index (RSI) | 71.16 | 53.84 |
| Support Level | $57.44 | $573.31 |
| Resistance Level | $59.30 | $608.06 |
| Average True Range (ATR) | 2.14 | 22.96 |
| MACD | 0.82 | 0.30 |
| Stochastic Oscillator | 91.35 | 54.79 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CVCO Cavco Industries Inc. When Issued
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.